St A Nunes FA and Lucey MR |
Searching for a balance when applying immunosuppression after liver transplantation. |
2001 |
Transplantation |
pmid:11258425
|
Ringe B et al. |
A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil. |
2001 |
Transplantation |
pmid:11258429
|
Matsuda S et al. |
Two distinct action mechanisms of immunophilin-ligand complexes for the blockade of T-cell activation. |
2000 |
EMBO Rep. |
pmid:11258483
|
Queille-Roussel C et al. |
The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study. |
2001 |
Br. J. Dermatol. |
pmid:11260007
|
Weir MR et al. |
Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy. |
2001 |
Kidney Int. |
pmid:11260422
|
Chand DH et al. |
Tacrolimus: the good, the bad, and the ugly. |
2001 |
Pediatr Transplant |
pmid:11260486
|
Grotz WH et al. |
Calcineurin-inhibitor induced pain syndrome (CIPS): a severe disabling complication after organ transplantation. |
2001 |
Transpl. Int. |
pmid:11263551
|
Nikiforow S et al. |
CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation. |
2001 |
J. Virol. |
pmid:11264363
|
Vasquez E et al. |
Clotrimazole increases tacrolimus blood levels: a drug interaction in kidney transplant patients. |
2001 |
Clin Transplant |
pmid:11264634
|
Nagashima N et al. |
Decreased effect of immunosuppression on immunocompetence in African--Americans after kidney and liver transplantation. |
2001 |
Clin Transplant |
pmid:11264637
|
Ciancio G et al. |
The use of intravenous tacrolimus and mycophenolate mofetil as induction and maintenance immunosuppression in simultaneous pancreas--kidney recipients with previous transplants. |
2001 |
Clin Transplant |
pmid:11264642
|
Utsugi R et al. |
Tolerance across a two-haplotype, fully MHC-mismatched barrier induced in miniature swine renal allografts treated with a 12-day course of tacrolimus. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11266727
|
Gasser M et al. |
Putative regulatory function of alloreactive Th2 cells in tolerant recipients after small bowel transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11266759
|
Nakao A et al. |
Changes of allo-intestinal graft survival and intragraft cytokine expression by bone marrow augmentation with tacrolimus treatment in rats. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11266851
|
Janezic AL et al. |
Alternatively spliced variants of IL-2 mRNA in sequential transplant kidney core needle biopsies. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11266873
|
Opelz G |
New immunosuppressants and HLA matching. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11266911
|
Jiang H et al. |
IL-10: a tacrolimus-specific cytotoxic mediator in ongoing allograft rejection. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11266931
|
Orsenigo R et al. |
FK506 and SMS 201-995: effect on heterotopic heart transplantation in rats. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11266956
|
Ishibashi M et al. |
Experimental study of tacrolimus immunosuppression on the mode of administration: efficacy of constant intravenous infusion avoiding C(max). |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11266958
|
Erickson LM et al. |
Gene expression profiles of rat heart allografts with immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11266960
|
Reutzel-Selke A et al. |
Donor pretreatment of grafts from marginal donors improves long-term graft outcome. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267150
|
Ettenger R |
The practical problems of prednisone in pediatric renal transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267159
|
Berloco P et al. |
Tacrolimus as cornerstone immunosuppressant in kidney transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267161
|
Ciancio G et al. |
Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267169
|
Vincenti F |
Tacrolimus (FK 506) in kidney transplantation: five-year survival results of the U.S. multicenter, randomized, comparative trial. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267172
|
Calconi G and Vianello A |
One-year follow-up of a large European trial comparing dual versus triple tacrolimus-based immunosuppressive regimens following renal transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267173
|
Pretagostini R et al. |
Conversion from cyclosporin to tacrolimus in chronic allograft nephropathy. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267174
|
Abouljoud M et al. |
Conversion to neoral provides effective rescue therapy for liver and kidney transplant patients intolerant of Prograf. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267175
|
Kauffman HM et al. |
Drug regimens affect cadaveric kidney graft survival. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267176
|
Dudley CR |
Conversion at first rejection: a prospective trial comparing cyclosporine microemulsion with tacrolimus in renal transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267179
|
Wang W et al. |
Effect of rapamycin and FK506 on mesangial cell proliferation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267180
|
Salazar A et al. |
Sirolimus-tacrolimus combination for combined kidney-pancreas transplantation: effect on renal function. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267181
|
Zaltzman J et al. |
Tacrolimus, MMF, steroid, and ALG immunotherapy for high immunological risk renal transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267183
|
Zamauskaite A et al. |
FK506 and CsA differ in their effect on intracellular cytokine expression following kidney transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267184
|
Aguirrezabalaga J et al. |
Lipid profiles in liver transplantation in patients receiving tacrolimus or cyclosporin. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267192
|
Shishido S et al. |
Pharmacokinetics of tacrolimus in pediatric renal transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267193
|
Glanemann M et al. |
Mycophenolate mofetil is superior in combination with tacrolimus compared to cyclosporine for immunosuppressive therapy after liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267194
|
van den Berg AP et al. |
Prediction of the inhibition of IL-2 production by calcineurin inhibitors. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267197
|
Wu M et al. |
Cyclosporine and tacrolimus alter renin-angiotesin system in mouse medullary-thick ascending limb cultured cells. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267198
|
Luke PP et al. |
IVIG rescue therapy in renal transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267206
|
Felipe CR et al. |
Choosing the right dose of new immunossuppressive drugs for new populations: importance of pharmacokinetic studies. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267207
|
Evans NJ et al. |
The expression of endothelin and inducible nitric oxide synthase in human renal allografts and their role in chronic renal allograft nephropathy. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267247
|
Cailhier JF et al. |
CMV in kidney transplants in the tacrolimus-mycophenolate era. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267255
|
Quiroga I et al. |
Differential homocysteine levels in renal transplant patients receiving neoral versus tacrolimus. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267261
|
Chakrabarti P et al. |
Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267274
|
Del Castillo D |
Analysis of primary and recurrent rejection following renal transplantation in a large, comparative, multicentre trial. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267283
|
Busque S et al. |
Canadian multicentre trial of tacrolimus/azathioprine/steroids versus tacrolimus/mycophenolate mofetil/steroids versus neoral/mycophenolate mofetil/steroids in renal transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267285
|
Sperschneider H |
A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267291
|
Mühlbacher F |
Tacrolimus versus cyclosporin microemulsion in liver transplantation: results of a 3-month study. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267317
|
Peltekian K et al. |
De novo use of low-dose tacrolimus and sirolimus in liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267318
|
Jain A et al. |
Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: complete report on 350 primary adult liver transplantations. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267319
|
Mueller AR et al. |
Influence of immunosuppression on patient survival after liver transplantation for hepatitis C. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267321
|
Mohamed MA et al. |
TGF-beta expression in protocol transplant liver biopsies: a comparative study between cyclosporine-A (CyA) and tacrolimus (FK 506) immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267336
|
Shokouh-Amiri MH et al. |
The importance of early prevention of renal dysfunction in liver transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267345
|
Markus BH et al. |
Daclizumab induction therapy in combination with tacrolimus. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267354
|
Langrehr JM et al. |
IL-2 receptor antibody induction increases the risk for chronic rejection after liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267360
|
Heffron TG et al. |
Single-dose induction with daclizumab immediately after liver transplantation in pediatric patients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267368
|
Groetzner J et al. |
Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: which treatment reveals more side effects during long-term follow-up? |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267373
|
van den Berg AP et al. |
Recurrent HCV infection reduces the requirement for tacrolimus after liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267375
|
Pirenne J et al. |
Standard cyclosporine A-based versus completely steroid-free FK506-based immunosuppression after liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267396
|
Langrehr JM et al. |
A prospective, randomized trial with quadruple versus dual tacrolimus-based induction after liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267404
|
Heffron TG et al. |
Daclizumab induction in liver transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267408
|
Rabkin JM et al. |
Pharmacoeconomic study of tacrolimus-based versus cyclosporine-based immunosuppressive therapy following liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267411
|
Uber PA et al. |
Ethnic disparities in the pharmacologic characteristics of tacrolimus in heart transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267428
|
Banerjee R et al. |
Coadministration of itraconazole and tacrolimus after thoracic organ transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267435
|
Mehra MR et al. |
A randomized comparison of an immunosuppressive strategy using tacrolimus and cyclosporine in black heart transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267438
|
Mehra MR et al. |
Racial differences in clinical outcome using tacrolimus and mycophenolate mofetil immunosuppression in heart transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267442
|
Treede H et al. |
Incidence and spectrum of infections in lung transplanted patients: comparison of four different immunosuppressive protocols. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267444
|
Jordan ML et al. |
Steroid withdrawal for pancreas transplants under tacrolimus immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267456
|
Lo A et al. |
Outcome of simultaneous kidney-pancreas transplantation in African-American recipients: a case control study. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267465
|
Burke GW et al. |
Ten-year survival after simultaneous pancreas/kidney transplantation with bladder drainage and tacrolimus-based immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267467
|
Kahl A et al. |
Long-term prednisolone withdrawal after pancreas and kidney transplantation in patients treated with ATG, tacrolimus, and mycophenolate mofetil. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267473
|
McCauley J et al. |
Long-term lipid metabolism in combined kidney-pancreas transplant recipients under tacrolimus immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267475
|
Lo A et al. |
Limited benefits of induction with monoclonal antibody to interleukin-2 receptor in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous kidney-pancreas transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267477
|
Owen ER et al. |
Peripheral nerve regeneration in human hand transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267484
|
Molmenti EP et al. |
Incidence, management, and outcome of posttransplant lymphoproliferative disease in pediatric liver transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267487
|
Spada M et al. |
A cause of late graft dysfunction after liver transplantation in children: de-novo autoimmune hepatitis. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267495
|
Lo A et al. |
Ganciclovir prophylaxis for cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267516
|
Reimer J et al. |
Quality of life after kidney transplantation--the impact of tacrolimus. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267573
|
Jain A et al. |
Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus. |
2001 |
J Clin Pharmacol |
pmid:11269567
|
Bekersky I et al. |
Effect of time of meal consumption on bioavailability of a single oral 5 mg tacrolimus dose. |
2001 |
J Clin Pharmacol |
pmid:11269569
|
Ericzon B et al. |
Glucose metabolism in liver transplant recipients treated with FK 506 or cyclosporin in the European multicentre study. |
1994 |
Transpl. Int. |
pmid:11271178
|
Undre N and Möller A |
Pharmacokinetic interpretation of FK 506 levels in blood and in plasma during a European randomised study in primary liver transplant patients. The FK 506 European Study Group. |
1994 |
Transpl. Int. |
pmid:11271189
|
Yano K et al. |
Effects of intrahepatic arterial and intraportal administration of FK 506 on liver allograft survival in rats. |
1994 |
Transpl. Int. |
pmid:11271200
|
Devlin J et al. |
Renal complications and development of hypertension in the European study of FK 506 and cyclosporin in primary liver transplant recipients. |
1994 |
Transpl. Int. |
pmid:11271207
|
|
Two-year follow-up study of the efficacy and safety of FK 506 in kidney transplant patients. Japanese FK 506 Study Group. |
1994 |
Transpl. Int. |
pmid:11271216
|
Neuhaus P et al. |
Neurological complications in the European multicentre study of FK 506 and cyclosporin in primary liver transplantation. |
1994 |
Transpl. Int. |
pmid:11271222
|
Bismuth H et al. |
Focus on intractable rejection: 6-month results of the European multicentre liver study of FK 506 and cyclosporin A. |
1994 |
Transpl. Int. |
pmid:11271231
|
McMaster P |
Patient and graft survival in the European Multicentre Liver Study--FK 506 vs cyclosporin A. |
1994 |
Transpl. Int. |
pmid:11271239
|
Mueller AR et al. |
Neurotoxicity after orthotopic liver transplantation in cyclosporin A- and FK 506-treated patients. |
1994 |
Transpl. Int. |
pmid:11271254
|
D'Silva M et al. |
The immunomodulatory effects of a novel agent, leflunomide, in rat cardiac allotransplantation. |
1994 |
Transpl. Int. |
pmid:11271257
|
Trocha K et al. |
Neurological examinations after liver transplantation concerning patients under corticosteroid immunosuppression and either FK 506 or cyclosporin. |
1994 |
Transpl. Int. |
pmid:11271273
|
Ishii T et al. |
Immunodepressants ameliorate normothermic ischemia injury to the rat liver by down-regulating tumor necrosis factor, not by alleviation of lipid peroxidative injury. |
1994 |
Transpl. Int. |
pmid:11271294
|
Platz KP et al. |
Nephrotoxicity after orthotopic liver transplantation in cyclosporin A and FK 506-treated patients. |
1994 |
Transpl. Int. |
pmid:11271297
|
Metcalfe S et al. |
FK 506 and cyclosporin each block antigen-induced T cell receptor signalling that is dependent on CD4 co-receptor and operates in the absence of detectable cytoplasmic calcium fluxes. |
1994 |
Transpl. Int. |
pmid:11271304
|
Moutabarrik A et al. |
Effect of immunosuppressive agents FK 506 and cyclosporin and steroids on the expression of IL-6 and its receptor by stimulated lymphocytes and monocytes. |
1994 |
Transpl. Int. |
pmid:11271305
|
Winkler M et al. |
Optimal FK 506 dosage in patients under primary immunosuppression following liver transplantation. |
1994 |
Transpl. Int. |
pmid:11271312
|
Devlin J et al. |
FK 506 primary immunosuppression following emergency liver transplantation for fulminant hepatic failure. European FK 506 Study Liver Group. |
1994 |
Transpl. Int. |
pmid:11271328
|
Otto G et al. |
Corticosteroids and concomitant medication in the European multicentre study of FK 506 and cyclosporin in primary liver transplantation. |
1994 |
Transpl. Int. |
pmid:11271338
|
Wong P et al. |
FK 506 rescue therapy for intractable liver allograft rejection. |
1994 |
Transpl. Int. |
pmid:11271339
|